Document Detail


Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells.
MedLine Citation:
PMID:  19318565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Estrogen receptor alpha (ERalpha) is a nuclear receptor that functions as a ligand-activated transcription factor. Besides its genomic action in nuclei, ERalpha could exert nongenomic actions at the plasma membrane. To investigate the mechanism underlying the nongenomic action of ERalpha in breast cancer cells, we generated a construct of membrane-targeted ERalpha (memER), an expression vector of ERalpha without the nuclear localizing signal and including instead the membrane-targeting sequence of Src kinase. MemER was stably expressed in human breast cancer MCF-7 cells. Cell migration test and tumorigenic assay in nude mice revealed that the in vitro motility and the in vivo proliferation activity of MCF-7 cells expressing memER were significantly enhanced compared with those of vector-transfected cells. Interestingly, the acetylation level of tubulin in memER-overexpressing cells was lower than that in control cells. We found that histone deacetylase (HDAC) 6 translocated to the plasma membrane shortly after estrogen stimulation, and rapid tubulin deacetylation subsequently occurred. We also showed that memER associated with HDAC6 in a ligand-dependent manner. Although tamoxifen is known for its antagonistic role in the ERalpha genomic action in MCF-7 cells, the agent showed an agonistic function in the memER-HDAC6 association and tubulin deacetylation. These findings suggest that ERalpha ligand dependently forms a complex with HDAC6 and tubulin at the plasma membrane. Estrogen-dependent tubulin deacetylation could provide new evidence for the nongenomic action of estrogen, which potentially contributes to the aggressiveness of ERalpha-positive breast cancer cells.
Authors:
Kotaro Azuma; Tomohiko Urano; Kuniko Horie-Inoue; Shin-ichi Hayashi; Ryuichi Sakai; Yasuyoshi Ouchi; Satoshi Inoue
Related Documents :
14526435 - Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and hu...
7654325 - Expression of clusterin in cell differentiation and cell death.
19584265 - Matrix protein ccn1 is critical for prostate carcinoma cell proliferation and trail-ind...
11026755 - Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol an...
2478355 - Vitronectin production by human yolk sac carcinoma cells resembling parietal endoderm.
8517865 - Development and characterization of hydrogen peroxide-resistant chinese hamster ovary c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-03-24
Journal Detail:
Title:  Cancer research     Volume:  69     ISSN:  1538-7445     ISO Abbreviation:  Cancer Res.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-02     Completed Date:  2009-06-02     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2935-40     Citation Subset:  IM    
Affiliation:
Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylation
Animals
Breast Neoplasms / metabolism*
COS Cells
Cell Line, Tumor
Cell Membrane / metabolism
Cell Movement / physiology
Cercopithecus aethiops
Estradiol / pharmacology
Estrogen Receptor alpha / metabolism*
Histone Deacetylases / metabolism*
Humans
Tubulin / metabolism*
Chemical
Reg. No./Substance:
0/Estrogen Receptor alpha; 0/Tubulin; 50-28-2/Estradiol; EC 3.5.1.98/HDAC6 protein, human; EC 3.5.1.98/Histone Deacetylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori protei...
Next Document:  Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.